Two startups with links to the University at Buffalo are part of the initial 18 companies chosen for a national event next month meant to build closer ties and promote innovation among global firms, universities and entrepreneurs.
ZOETIC Pharmaceuticals, a UB spinoff, and Garwood Medical Devices, a UB technology licensee, will present at University Startups Demo Day on Sept. 20 in Washington, D.C.
Seventeen other startup companies will be announced as participants next week.
In all, 35 companies will make presentations to company executives, venture capitalists and angel investors, according to UB. The startups also will visit congressional offices to tout the importance of universities to the economy.
ZOETIC is an early stage drug development company that licensed a technology, invented at UB, to improve the performance and safety of therapies for autoimmune diseases, genetic disorders and other conditions that are treated with biologic drugs. The drugs are genetically-engineered proteins formed from human genes.
Garwood, which also has licensed several UB technologies, develops devices to treat chronic wounds and control joint-replacement infections. The company intends to create 40 jobs over five years through a partnership with UB’s Buffalo Institute for Genomics and Data Analytics, which will provide Garwood with $1.48 million in support.